US2005266517A1PendingUtilityA1
Transformant containing transaldolase gene
Est. expirySep 21, 2019(expired)· nominal 20-yr term from priority
C12N 9/1022C12Y 202/01002C12N 9/10
50
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to a novel transaldolase gene, and to a polypeptide encoded by the gene, a recombinant DNA obtained by ligating the gene, a transformant carrying the recombinant DNA, and a process for producing the polypeptide, aromatic amino acids, aromatic vitamins, L-histidine, riboflavin, nucleic acids, nucleic acid-associated substances, novel saccharides and others by utilizing the transformant.
Claims
exact text as granted — not AI-modified1 - 8 . (canceled)
9 . A transformant in which one or more nucleotides have been substituted, deleted or inserted in the nucleotide sequence of the DNA carried by the transformant of claim 10 or in the nucleotide sequence of a DNA existing upstream the DNA and participating in transcription and translation, and of which the transaldolase activity is enhanced over that of the transformant not having undergone the substitution, deletion or insertion.
10 . A transformant comprising a recombinant DNA obtained by ligating a DNA to a vector said DNA coding for a polypeptide having transaldolase activity and comprising (i) SEQ ID NO:2, (ii) a DNA coding for the amino acid sequence of SEQ ID NO: 1 (iii) a DNA coding for an amino sequence which is at least 60% homologous to SEQ ID NO: 1 and (iv) a DNA hybridizing to any of (i)-(iii) at 62° C. in the presence of 0.7-1.0 mol/l NaCl followed by washing at 65° C. with 0.1-2.0 X SSC, wherein the transformant has an ability to produce an aromatic amino acid or aromatic vitamin.
11 . A process for producing an aromatic amino acid or aromatic vitamin, which comprises:
culturing the transformant of claim 10 in a medium to thereby produce and accumulate in the culture the aromatic amino acid or aromatic vitamin, and recovering the aromatic amino acid or aromatic vitamin from the culture.
12 . (canceled)
13 . The transformant according to claim 10 , wherein the transformant has a reduced ability to produce a substance selected from L-histidine, riboflavin and nucleic acids.
14 . A process for producing a substance, which comprises:
culturing the transformant of claim 13 in a medium to thereby produce and accumulate the substance in the culture, and recovering the substance from the culture.
15 - 16 . (canceled)
17 . A process for producing an aromatic amino acid or aromatic vitamin, which comprises:
culturing the transformant of claim 9 in a medium to thereby produce and accumulate in the culture the aromatic amino acid or aromatic vitamin, and recovering the aromatic amino acid or aromatic vitamin from the culture.
18 . The transformant according to claim 9 , wherein the transformant has a reduced ability to produce a substance selected from L-histidine, riboflavin and nucleic acids.
19 . A process for producing a substance, which comprises:
culturing the transformant of claim 18 in a medium to thereby produce and accumulate the substance in the culture, and recovering the substance from the culture.Join the waitlist — get patent alerts
Track US2005266517A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.